Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Alnylam Pharmaceuticals (ALNY) Q1 2024 Earnings
ALNY
15
Feb
Confirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-2.21
-0.89
0.42
1.74
Details
Expected EPS
-1.26
Actual EPS
-0.77
Surprise EPS
0.49
Surprise Percent
+38.89%
Description
Alnylam Pharmaceuticals (ALNY) has reported earnings of -0.77 per share for Q1 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login